tiprankstipranks
GLHL
Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF DR- EUR
Advertisement

FR:GLHL ETF Price & Analysis

Compare

GLHL ETF Chart & Stats

€12.01
--
Market closed
€12.01
--

ETF Overview

Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF DR- EUR

The Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF DR- EUR, trading under the ticker FR:GLHL, is a specialized investment vehicle designed for investors seeking to capitalize on the dynamic and essential health care sector. This exchange-traded fund offers exposure to a broad array of global health care companies that meet stringent environmental, social, and governance (ESG) criteria, as outlined by the S&P World Sustainability Enhanced Health Care Index. The ETF is particularly appealing to those interested in ESG-conscious investments, as it meticulously screens for companies that not only lead in health care innovation and service but also adhere to sustainable and responsible business practices. By focusing on the health care sector, the fund taps into a market characterized by continuous growth driven by aging populations, technological advancements, and increasing health awareness worldwide. As a UCITS-compliant fund, it adheres to strict European regulatory standards, ensuring a high level of investor protection and transparency. With its sector-focused strategy within a broad-based niche, the Amundi S&P World Health Care Screened UCITS ETF DR- EUR provides a balanced and sustainable approach to participating in the global health care industry's potential, making it an attractive option for discerning investors.

Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF DR- EUR (GLHL) Fund Flow Chart

Amundi ETF ICAV - Amundi S&P World Health Care Screened UCITS ETF DR- EUR (GLHL) 1 year Net Flows: €283M

GLHL ETF News

GLHL ETF FAQ

What was FR:GLHL’s price range in the past 12 months?
FR:GLHL lowest ETF price was €9.96 and its highest was €12.27 in the past 12 months.
    What is the AUM of FR:GLHL?
    As of Sep 04, 2026 The AUM of FR:GLHL is 568.53M.
      Is FR:GLHL overvalued?
      According to Wall Street analysts FR:GLHL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does FR:GLHL pay dividends?
        FR:GLHL does not currently pay dividends.
        How many shares outstanding does FR:GLHL have?
        Currently, no data Available
        Which hedge fund is a major shareholder of FR:GLHL?
        Currently, no hedge funds are holding shares in FR:GLHL

        GLHL ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Eli Lilly And Company
        11.50%
        Abbvie
        8.19%
        Merck & Company
        5.64%
        Novartis
        4.97%
        Unitedhealth Group Inc.
        4.67%
        AstraZeneca plc
        4.18%
        Amgen Inc
        4.10%
        Roche Holding
        3.79%
        Gilead Sciences
        3.44%
        Thermo Fisher Scientific
        2.86%
        Total53.32%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement